Combined liver and pancreatic islets transplantation in man using cyclosporin immunosuppression

Transpl Int. 1994:7 Suppl 1:S409-11. doi: 10.1111/j.1432-2277.1994.tb01405.x.

Abstract

We report a 1-year patient and graft survival after combined liver-pancreatic islet transplantation. The patient was affected by a pancreatic neuroendocrine carcinoma with extensive liver metastasis. Native pancreas and total liver removal was undertaken after a good response to chemotherapy, and the patient was still cancer-free 1 year later. Normal liver function and insulin independence was achieved, although islet response to glucose challenge remained delayed. Immunosuppression was maintained with cyclosporin monotherapy.

Publication types

  • Case Reports

MeSH terms

  • Cyclosporine / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Insulin / blood
  • Islets of Langerhans Transplantation / methods
  • Islets of Langerhans Transplantation / physiology*
  • Liver Function Tests
  • Liver Neoplasms / secondary
  • Liver Neoplasms / surgery
  • Male
  • Middle Aged
  • Neuroendocrine Tumors / surgery
  • Pancreatic Neoplasms / surgery
  • Time Factors
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Insulin
  • Cyclosporine